The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

By sjmartinez • January 19, 2025

Packard RRS. The clinical promise of ¹⁸F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.

Tags: Cardiology/Epi, Publications

Immune Checkpoint Inhibitor Myocarditis Masquerading as Brugada Syndrome

Talishinsky A, Bachour K, Lin C, Zakka P, Bassam K, Bull L, Garon E, Krokhaleva Y, Hanna P, Yang EH. Immune Checkpoint Inhibitor Myocarditis Masquerading[...]

Glia of the heart’s nervous system

Scherschel K, Wolf H, Ajijola OA, Shivkumar K, Lindner D, Gomez-Sanchez JA, Meyer C. Glia of the heart's nervous system. Nat Rev Neurosci. 2025 Oct[...]

Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States

Mac Grory B, Asif KS, Xu H, Alhanti B, Lusk J, Hasan D, Park S, Boehme AK, Zachrison KS, Goyal M, Southerland AM, Jadhav A,[...]